Association of Tumor <i>HER3</i> Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer
Jenny F. Seligmann(University of Leeds), Michel Seymour(University of Leeds), Herbert I. Hurwitz(Duke Medical Center), Faye Elliott(University of Leeds), Philip Quirke(University of Leeds), Bart Jacobs, Jennifer H. Barrett(University of Leeds), Sarah Brown(University of Leeds), Susan D. Richman(University of Leeds), Ace J. Hatch(Duke Medical Center), Andrew B. Nixon(Duke University)
Cited by 29
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k